CD8A and neoplasm: TMTP1-TSRP-EVs effectively remodel the tumor microenvironment by increasing the infiltration of M1 macrophages and CD8+ T cells while reducing M2 macrophage infiltration, thereby enhancing anti-tumor immune responses and providing new therapeutic strategies.